Abrogated USP7 expression promotes CD8+ T cell proliferation, elevates tumor necrosis factor (TNF) alpha and interferon gamma (IFN-γ) levels, and inhibits glioma cell immune evasion, which can be reversed by PD-L1 overexpression (18). The gene discussed is USP7; the disease is glioma.